Sangamo Therapeutics
Insider trading & Transactions

Last updated: 5 Jan 2015

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	5 Jan 2015	LARSON JOHN WILLIAM director director	Stock Option (Right to Buy)	5,000	N/A	N/A
Option	5 Jan 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	5 Jan 2015	RINGO WILLIAM R director director	Common Stock	2,200	N/A	N/A
Sale	5 Jan 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	5 Jan 2015	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	1,500	N/A	N/A
Option	5 Jan 2015	RINGO WILLIAM R director director	Stock Option (Right to Buy)	2,200	N/A	N/A
Option	5 Jan 2015	RINGO WILLIAM R director director	Common Stock	2,200	N/A	N/A
Sale	2 Jan 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	2 Jan 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	2 Jan 2015	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	15 Dec 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Option	15 Dec 2014	LARSON JOHN WILLIAM director director	Common Stock	15,000	N/A	N/A
Option	15 Dec 2014	LARSON JOHN WILLIAM director director	Stock Option (Right to Buy)	15,000	N/A	N/A
Option	15 Dec 2014	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Sale	15 Dec 2014	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	15 Dec 2014	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	25,000	N/A	N/A
Option	11 Dec 2014	MENTO STEVEN J director director	Common Stock	10,000	N/A	N/A
Option	11 Dec 2014	MENTO STEVEN J director director	Employee Stock Option (Right to Buy)	10,000	N/A	N/A
Option	11 Dec 2014	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Employee Stock Option (Right to Buy)	150,000	N/A	N/A
Option	11 Dec 2014	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	37,500	N/A	N/A
Sale	11 Dec 2014	MENTO STEVEN J director director	Common Stock	6,354	N/A	N/A
Option	9 Dec 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Sale	9 Dec 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Option	9 Dec 2014	LARSON JOHN WILLIAM director director	Stock Option (Right to Buy)	10,000	N/A	N/A
Option	5 Dec 2014	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	5 Dec 2014	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	5 Dec 2014	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	1 Dec 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	1 Dec 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	1 Dec 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	17 Nov 2014	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	17 Nov 2014	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	17 Nov 2014	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	25,000	N/A	N/A
Option	12 Nov 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Option	12 Nov 2014	LARSON JOHN WILLIAM director director	Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	12 Nov 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Sale	10 Nov 2014	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	2,000	N/A	N/A
Option	5 Nov 2014	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Option	5 Nov 2014	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Sale	5 Nov 2014	ANDO DALE G officer: VP, Therapeutic Dev. & CMO officer: VP, Therapeutic Dev. &..	Common Stock	15,000	N/A	N/A
Option	3 Nov 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Employee Stock Option (Right to Buy)	15,000	N/A	N/A
Sale	3 Nov 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	3 Nov 2014	GREGORY PHILIP D officer: SVP of Research & CSO officer: SVP of Research & CSO	Common Stock	15,000	N/A	N/A
Option	28 Oct 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Option	28 Oct 2014	LARSON JOHN WILLIAM director director	Stock Option (Right to Buy)	10,000	N/A	N/A
Sale	28 Oct 2014	LARSON JOHN WILLIAM director director	Common Stock	10,000	N/A	N/A
Sale	15 Oct 2014	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	15 Oct 2014	LANPHIER EDWARD O II director director	Common Stock	25,000	N/A	N/A
Option	15 Oct 2014	LANPHIER EDWARD O II director director	Employee Stock Option (Right to Buy)	25,000	N/A	N/A
Sale	10 Oct 2014	WOLFF HENRY WARD officer: Exec VP & CFO officer: Exec VP & CFO	Common Stock	2,000	N/A	N/A

Showing 300 to 350 of 1018 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Sangamo Therapeutics Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

Sangamo Therapeutics
Insider trading & Transactions